“We’re often giving [patients] immunosuppressants that require a lot of lab monitoring, a lot of drug interactions, a lot of potential side effects, and they’re making people feel slightly better, but not completely clear,” Maloney…
Treating Dermatology Patients with Off-Label JAK Inhibitors, With Gabriela Maloney, DO
